Improving Asthma Management: The Case for Mandatory Inclusion of Dose Counters on All Rescue Bronchodilators

por Conner, Jill B., Buck, Philip O.
Publicado 2013

Time and cost of administering COVID-19 mRNA vaccines in the United States

por Yarnoff, Benjamin, Bodhaine, Steven, Cohen, Ed, Buck, Philip O.
Publicado 2021

Psychometric validation of the revised SCOPA-Diary Card: expanding the measurement of non-motor symptoms in parkinson's disease

por Rendas-Baum, Regina, Buck, Philip O, White, Michelle K, Castelli-Haley, Jane
Publicado 2011

Age-appropriate compliance and completion of up to five doses of pertussis vaccine in US children

por Krishnarajah, Girishanthy, Malangone-Monaco, Elisabetta, Palmer, Liisa, Riehle, Ellen, Buck, Philip O.
Publicado 2018

Alcohol and Sexual Assault

por Abbey, Antonia, Zawacki, Tina, Buck, Philip O., Clinton, A. Monique, McAuslan, Pam
Publicado 2001

Hepatitis A and B vaccination in adults at risk: A survey of US healthcare providers’ attitudes and practices

por Herrera-Restrepo, Oscar, Davis, Kimberly, Sweeney, Carolyn, Davenport, Eric, Ghaswalla, Parinaz, Buck, Philip O.
Publicado 2022

Is patient insurance type related to physician recommendation, administration and referral for adult vaccination? A survey of US physicians

por McNamara, Michelle, Buck, Philip O., Yan, Songkai, Friedland, Leonard R., Lerch, Kristin, Murphy, Alysa, Hogea, Cosmina
Publicado 2019

A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control

por Ray, Riju, Dos Santos, Gaël, Buck, Philip O., Claeys, Carine, Matias, Gonçalo, Innis, Bruce L., Bekkat-Berkani, Rafik
Publicado 2017

Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration Project

por Standaert, Baudouin, Van Vlaenderen, Ilse, Van Bellinghen, Laure-Anne, Talbird, Sandra, Hicks, Katherine, Carrico, Justin, Buck, Philip O.
Publicado 2019

17. Assessment of Recombinant Zoster Vaccine Second Dose Completion in the United States

por Patterson, Brandon J, Chen, Chi-Chang, McGuiness, Catherine B, Glasser, Lisa I, Sun, Kainan, Buck, Philip O
Publicado 2020

Early examination of real-world uptake and second-dose completion of recombinant zoster vaccine in the United States from October 2017 to September 2019

por Patterson, Brandon J., Chen, Chi-Chang, McGuiness, Catherine B., Glasser, Lisa I., Sun, Kainan, Buck, Philip O.
Publicado 2021

Burden of asthma with elevated blood eosinophil levels

por Casciano, Julian, Krishnan, Jerry A., Small, Mary Buatti, Buck, Philip O., Gopalan, Gokul, Li, Chenghui, Kemp, Robert, Dotiwala, Zenobia
Publicado 2016

Value of peripheral blood eosinophil markers to predict severity of asthma

por Casciano, Julian, Krishnan, Jerry A., Small, Mary Buatti, Buck, Philip O., Gopalan, Gokul, Li, Chenghui, Kemp, Robert, Dotiwala, Zenobia
Publicado 2016

Estimated incidence of pertussis in people aged <50 years in the United States

por Chen, Chi-Chang, Balderston McGuiness, Catherine, Krishnarajah, Girishanthy, Blanchette, Christopher M., Wang, Yuanyuan, Sun, Kainan, Buck, Philip O.
Publicado 2016

Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live

por Curran, Desmond, Patterson, Brandon J., Van Oorschot, Desiree, Buck, Philip O., Carrico, Justin, Hicks, Katherine A., Lee, Bruce, Yawn, Barbara P.
Publicado 2019

Estimated Public Health Impact of the Recombinant Zoster Vaccine

por Patterson, Brandon J., Buck, Philip O., Curran, Desmond, Van Oorschot, Desirée, Carrico, Justin, Herring, William L., Zhang, Yuanhui, Stoddard, Jeffrey J.
Publicado 2021

Vaccinating Adolescents and Children Significantly Reduces COVID-19 Morbidity and Mortality across All Ages: A Population-Based Modeling Study Using the UK as an Example

por Shiri, Tinevimbo, Evans, Marc, Talarico, Carla A., Morgan, Angharad R., Mussad, Maaz, Buck, Philip O., McEwan, Phil, Strain, William David
Publicado 2021

The Population-Wide Risk-Benefit Profile of Extending the Primary COVID-19 Vaccine Course Compared with an mRNA Booster Dose Program

por Shiri, Tinevimbo, Evans, Marc, Talarico, Carla A., Morgan, Angharad R., Mussad, Maaz, Buck, Philip O., McEwan, Phil, Strain, William David
Publicado 2022

Factors associated with receipt of mRNA-1273 vaccine at a United States national retail pharmacy during the COVID-19 pandemic

por Roberts-McCarthy, Erin, Buck, Philip O., Smith-Ray, Renae L., Van de Velde, Nicolas, Singh, Tanya, Mansi, James, Shah, Amy, Taitel, Michael
Publicado 2023

A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development

por Fowler, Karen, Mucha, Jacek, Neumann, Monika, Lewandowski, Witold, Kaczanowska, Magdalena, Grys, Maciej, Schmidt, Elvira, Natenshon, Andrew, Talarico, Carla, Buck, Philip O., Diaz-Decaro, John
Publicado 2022